Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in 2019, Tellus BioVentures is a biotechnology investment fund based in the United States. The firm specializes in early-stage innovation and company formation, focusing on private biotech ventures at the Seed stage and participating in Series A investments. Tellus BioVentures aims to uncover and accelerate promising life science innovations, enabling talented entrepreneurs to develop therapeutics for patients with unmet medical needs.
The organization often acts as the lead or sole investor in its ventures, providing not only capital but also management support and development expertise. This dual approach helps portfolio companies achieve critical milestones and navigate the complexities of the biotech landscape. Tellus BioVentures has established itself as a key player in the biotech investment space, with a diverse portfolio that reflects its commitment to advancing significant innovations.
Tellus BioVentures invests primarily in private biotech ventures at the Seed stage, often taking the role of lead or sole investor. The firm also participates in Series A investments, allowing it to support companies as they transition from early development to more advanced stages. Their investment strategy includes launching and funding de novo companies that may lack the necessary resources to progress efficiently. This proactive approach enables Tellus to identify and nurture significant innovations in the life sciences sector.
The firm focuses on sectors such as biotech and healthcare, specifically targeting therapeutics for rare diseases, autoimmune diseases, and advanced cancer treatments. Tellus BioVentures seeks entrepreneurs who are dedicated to addressing unmet medical needs and are capable of navigating the challenges of biotech development. Their investment thesis emphasizes the importance of providing management support and development expertise to help portfolio companies achieve their goals.
Tellus BioVentures has built a diverse portfolio that includes several innovative companies in the biotech sector. Key portfolio companies include:
This portfolio reflects Tellus BioVentures' commitment to supporting groundbreaking advancements in the life sciences, particularly in areas where traditional funding may be scarce.
Lonnie Moulder - Managing Member. Lonnie has extensive experience in the biotech sector, having held leadership positions in various companies focused on drug development and commercialization.
Heidi Kempinski, MBA - Senior Principal & Operating Executive. Heidi brings a wealth of experience in operational management and strategic development within the life sciences industry.
Lauren Bartlett, MBA - Principal and Vice President of Commercial Development & Corporate Affairs. Lauren has a strong background in commercial strategy and corporate affairs, contributing to the growth of portfolio companies.
Meghan Lenihan Moulder, MS - Principal and Vice President of Portfolio Management. Meghan specializes in portfolio management and has a track record of guiding biotech companies through critical development phases.
Chris Moulder, MS, MBA - Principal and Vice President of Operations. Chris has expertise in operational strategy and management, ensuring that portfolio companies are well-supported in their growth efforts.
Founders interested in pitching to Tellus BioVentures should reach out through their website. A well-structured pitch deck should include details about the business model, market opportunity, and therapeutic innovations. While specific response time expectations are not provided, it is advisable to follow up after submitting a pitch to ensure it has been received.
In 2023, Tellus BioVentures has been actively involved in launching and funding de novo companies focused on significant innovations in the life sciences sector. Their portfolio continues to expand with projects aimed at addressing unmet medical needs, particularly in the areas of rare diseases and advanced cancer treatments.
As of October 2023, Tellus BioVentures remains committed to supporting early-stage biotech ventures, providing both capital and expertise to help these companies achieve their goals. The firm’s proactive approach to investment and company formation positions it as a key player in the biotech investment landscape.
What investment criteria does Tellus BioVentures have?
Tellus BioVentures focuses on early-stage biotech ventures, primarily at the Seed stage, and participates in Series A investments. They look for companies that are developing therapeutics for unmet medical needs, particularly in the biotech and healthcare sectors.
How can founders apply or pitch to Tellus BioVentures?
Founders interested in pitching to Tellus BioVentures should prepare a detailed presentation that outlines their business model, market opportunity, and the specific therapeutic innovations they are pursuing. While specific application forms are not mentioned, reaching out through their website is recommended.
What makes Tellus BioVentures different from other investors?
Tellus BioVentures distinguishes itself by often acting as the lead or sole investor in its ventures, providing not only capital but also management support and development expertise. This dual approach helps portfolio companies achieve critical milestones more effectively.
What is the geographic scope of Tellus BioVentures' investments?
Tellus BioVentures primarily invests in private biotech ventures based in the United States, focusing on companies that are addressing significant medical needs.
What is the typical check size for investments?
While specific check sizes are not disclosed, Tellus BioVentures typically invests at the Seed stage and participates in Series A rounds, often taking a leading role in funding.
What kind of post-investment involvement does Tellus BioVentures have?
Tellus BioVentures provides ongoing management support and development expertise to its portfolio companies, helping them navigate challenges and achieve their goals.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.